Pharma Industry News Tag - Passionate In Marketing https://www.passionateinmarketing.com/tag/pharma-industry-news/ Marketers in Conversation Wed, 04 Feb 2026 13:51:04 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://pimwp.s3-accelerate.amazonaws.com/2025/01/cropped-PIM-Logo-32x32.png Pharma Industry News Tag - Passionate In Marketing https://www.passionateinmarketing.com/tag/pharma-industry-news/ 32 32 Eris Lifesciences to consolidate its stake in Swiss Parenterals And welcome Naishadh Shah as a Top-10 Eris shareholder and Management https://www.passionateinmarketing.com/eris-lifesciences-to-consolidate-its-stake-in-swiss-parenterals-and-welcome-naishadh-shah-as-a-top-10-eris-shareholder-and-management/ https://www.passionateinmarketing.com/eris-lifesciences-to-consolidate-its-stake-in-swiss-parenterals-and-welcome-naishadh-shah-as-a-top-10-eris-shareholder-and-management/#respond Tue, 25 Nov 2025 08:29:30 +0000 https://www.passionateinmarketing.com/?p=650047 New Delhi, November 25th, 2025: Eris Lifesciences Limited (BSE: 540596; NSE: ERIS), today announced that its Board of Directors has approved the acquisition of the balance 30% stake in Swiss Parenterals Limited, a subsidiary. The proposed transaction will be effected as a share swap, i.e. through a preferential issuance of Eris equity shares to the seller Mr […]

The post Eris Lifesciences to consolidate its stake in Swiss Parenterals And welcome Naishadh Shah as a Top-10 Eris shareholder and Management appeared first on Passionate In Marketing.

]]> https://www.passionateinmarketing.com/eris-lifesciences-to-consolidate-its-stake-in-swiss-parenterals-and-welcome-naishadh-shah-as-a-top-10-eris-shareholder-and-management/feed/ 0 OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status https://www.passionateinmarketing.com/onesources-flagship-drug-device-combination-facility-in-bangalore-maintains-its-usfda-compliance-status/ https://www.passionateinmarketing.com/onesources-flagship-drug-device-combination-facility-in-bangalore-maintains-its-usfda-compliance-status/#respond Tue, 10 Jun 2025 18:02:35 +0000 https://www.passionateinmarketing.com/?p=615836 Bangalore, India, June 10, 2025 — OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a multi-modality specialty pharma pure-play CDMO, announced that its flagship facility in Bangalore, India, has received a “Voluntary Action Indicated” (VAI) classification from the U.S. Food and Drug Administration (USFDA), confirming its continued compliance. Following an inspection of the company’s flagship […]

The post OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status appeared first on Passionate In Marketing.

]]> https://www.passionateinmarketing.com/onesources-flagship-drug-device-combination-facility-in-bangalore-maintains-its-usfda-compliance-status/feed/ 0 The U.S. Subsidiary Of Senores Pharmaceuticals Appoints Gautam Shah As President Of U.S. Operations https://www.passionateinmarketing.com/the-u-s-subsidiary-of-senores-pharmaceuticals-appoints-gautam-shah-as-president-of-u-s-operations/ https://www.passionateinmarketing.com/the-u-s-subsidiary-of-senores-pharmaceuticals-appoints-gautam-shah-as-president-of-u-s-operations/#respond Tue, 06 May 2025 10:00:14 +0000 https://www.passionateinmarketing.com/?p=607033 Ahmedabad, India – May 6, 2025 – The U.S. subsidiary of Senores Pharmaceuticals Limited  (“SPL”), Havix Group Inc. D/B/A Aavis Pharmaceuticals, announces the appointment of Mr. Gautam Shah as President of U.S. Operations. This strategic move underscores the company’s  commitment to expanding its footprint in the regulated U.S. market.  Mr. Shah brings over three decades […]

The post The U.S. Subsidiary Of Senores Pharmaceuticals Appoints Gautam Shah As President Of U.S. Operations appeared first on Passionate In Marketing.

]]> https://www.passionateinmarketing.com/the-u-s-subsidiary-of-senores-pharmaceuticals-appoints-gautam-shah-as-president-of-u-s-operations/feed/ 0 Venus Remedies gets Marketing Authorization for anticoagulant ‘Enoxaparin’ from Indonesia https://www.passionateinmarketing.com/venus-remedies-gets-marketing-authorization-for-anticoagulant-enoxaparin-from-indonesia/ https://www.passionateinmarketing.com/venus-remedies-gets-marketing-authorization-for-anticoagulant-enoxaparin-from-indonesia/#respond Mon, 10 Feb 2025 12:45:23 +0000 https://www.passionateinmarketing.com/?p=589762 Latest approvals from Indonesia, Southeast Asia’s largest pharma market, to help strengthen company’s regional and global aspirations Bengaluru, February 10, 2025: Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading Indian exporter of generic drugs, has received marketing authorization from Indonesia, Southeast Asia’s largest pharmaceutical market, for its Enoxaparin in pre-filled syringes across all major […]

The post Venus Remedies gets Marketing Authorization for anticoagulant ‘Enoxaparin’ from Indonesia appeared first on Passionate In Marketing.

]]> https://www.passionateinmarketing.com/venus-remedies-gets-marketing-authorization-for-anticoagulant-enoxaparin-from-indonesia/feed/ 0